Trump admin limits fall COVID-19 boosters to seniors, high-risk groups; FDA calls for more data before broader approval.

【5月21日 ...

The United States will limit Covid-19 boosters to people over 65 or those at risk of serious illness, while requiring vaccine ...

India’s leading epidemiologist, Dr Raman Gangakhedkar has said that there is no cause for panic unless there is a noticeable ...

Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

米食品医薬品局（ＦＤＡ）は２０日、新型コロナウイルスのワクチン追加接種について、６５歳未満の健康な国民向けの実施承認に先立って新たな臨床試験を義務付ける計画を明らかにした。これにより追加接種の対象は事実上、高齢者と重症化リスクのある国民に限定される。

Covid-19 infections are again on the rise in parts of Asia, driven by two new subvariants called LF.7 and NB.1.8.

The Food and Drug Administration is shifting its annual COVID-19 vaccine approval policies to focus on Americans older than ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...